Georgia Braliou | Genetics and Molecular Biology | Research Excellence Award

Published on by Citation Awards

Georgia Braliou | Genetics and Molecular Biology | Research Excellence Award

University of Thessaly | Greece

Dr Braliou is a scientist specializing in Molecular Biology, Biochemistry, and Genetic Epidemiology. She obtained her academic training in Chemistry and later completed her PhD in Molecular Biology and Biochemistry through research conducted at leading European institutions, including the European Molecular Biology Laboratory and Radboud University Nijmegen. Her research primarily focuses on gene regulation mechanisms, including transcriptional control by nuclear receptors, cis-regulatory DNA elements, and epigenetic modifications. She has also contributed to understanding the regulation of hepcidin by hypoxia-induced factors during her postdoctoral work at the University of Thessaly. Expanding into computational biology and bioinformatics, her work integrates genetic epidemiology approaches, particularly in analyzing SNPs, gene expression, and GWAS data using statistical and computational methods.

Citation Metrics (Scopus)

800

600

400

200

0

Citations
637

Documents
28

h-index
12


View Scopus Profile
 View Google Scholar Profile
 View Orcid Profile
 View Scilit Profile
 View SciProfiles Profile

Featured Publications

Featured Publications


Antibody tests in detecting SARS-COV-2 infection: a meta-analysis
Diagnostics

– 2020 — Cited by 334

Transport of hypoxia-inducible factor HIF-1α into the nucleus involves importins 4 and 7
Biochemical and Biophysical Research Communications

– 2009 — Cited by 127

2-Oxoglutarate-dependent oxygenases control hepcidin gene expression

– Journal of Hepatology, 2008 — Cited by 98

Antioxidant Activity of Leaf Extracts from Stevia rebaudiana Bertoni: A Systematic Review and Meta-Analysis

–Nutrients, 2023 — Cited by 505

Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo

– The EMBO Journal, 1998 — Cited by 41

Reza Nekouian | Genetics and Molecular Biology | Pioneer Researcher Award

Published on by Citation Awards

Reza Nekouian | Genetics and Molecular Biology | Pioneer Researcher Award

Dr Reza Nekouian, Iran University of Medical Sciences, IUMS, Iran

Dr. Reza Nekouian, a seasoned faculty member at Iran University of Medical Sciences, brings over 17 years of expertise in cancer genetics and molecular diagnostics. Born on March 21, 1978, in Tehran, Iran, he has built a strong reputation in research design, academic teaching, and innovative cancer research solutions. Known for his problem-solving and leadership skills, Dr. Nekouian excels in guiding research teams and translating molecular findings into clinical applications. His academic contributions span across cancer genetics, molecular biology, and personalized medicine. In addition to being a dedicated educator in medical genetics and genetic engineering, he is also widely published in reputable journals. Dr. Nekouian is recognized for his collaborative spirit, exceptional communication, and passion for scientific innovation. His work significantly impacts early cancer detection and personalized treatments, aligning science with real-world health solutions.

Publication Profile

google scholar

Education

Dr. Reza Nekouian received his Ph.D. in Medical Biotechnology from Pune University, India, in 2007, where he specialized in cancer molecular biology and therapeutics. Prior to that, he completed his Master of Science (M.Sc.) in Health Sciences (Genetics) at the University of Pune in 2003. His academic journey reflects a focused pursuit of excellence in biotechnology and genetics, laying the foundation for his later contributions in cancer research and medical education. His studies in India exposed him to a rich scientific environment and equipped him with the latest tools in molecular genetics and biomedical research. These formative years nurtured his deep interest in translational medicine, setting him on a path to combine lab-based innovations with clinical cancer diagnostics. Dr. Nekouian’s educational background continues to fuel his research on biomarkers, cancer therapeutics, and molecular diagnostics, making him a valuable contributor to the global scientific and medical community.

Experience

Dr. Reza Nekouian has served as a faculty member and researcher at Iran University of Medical Sciences (IUMS) since February 2012. His core responsibilities include designing and managing cutting-edge research projects in cancer genetics, molecular diagnostics, and biomarker development for early cancer detection. He also actively contributes to advancing personalized medicine approaches in oncology. As a dedicated educator, Dr. Nekouian teaches theoretical and practical courses in medical genetics and genetic engineering, inspiring the next generation of scientists and clinicians. His professional journey spans over 17 years of impactful work at medical universities and research centers. He is recognized for his skill in resolving complex genetic and molecular research challenges, leading multidisciplinary teams, and publishing groundbreaking findings. With a focus on translational research, he bridges laboratory innovations with patient-centric medical applications, thereby improving diagnostic precision and therapeutic strategies in cancer treatment.

Awards and Honors

Although specific awards are not listed in the profile, Dr. Reza Nekouian’s extensive contributions to cancer genetics, personalized medicine, and molecular diagnostics have earned him academic distinction and professional recognition across Iranian and international research communities. His consistent publication in reputed journals, leadership in high-impact research, and role in educational development underscore his influence in the field. Dr. Nekouian has been instrumental in pioneering research programs and contributing to national strategies for cancer prevention and diagnosis. His invited roles in collaborative projects, advisory panels, and journal editorial activities serve as implicit recognition of his expertise. He is regularly consulted for complex research problem-solving and project development, particularly in molecular biology and biotechnology. Additionally, his leadership in implementing cancer control initiatives in the private health sector highlights his commitment to both scientific excellence and societal health advancement.

Research Focus

Dr. Reza Nekouian’s research centers on cancer genetics, with a specialized focus on the molecular mechanisms of tumorigenesis and biomarker discovery for early detection. His work explores the genetic regulation of cancer progression, using advanced diagnostic tools like circulating microRNAs and liposomal drug delivery systems. He also investigates personalized medicine approaches, including the role of gene expression and polymorphisms in cancer susceptibility and therapeutic response. A recurring theme in his research is the integration of molecular diagnostics with clinical oncology, aiming to improve diagnostic accuracy and treatment precision. Dr. Nekouian has contributed significantly to breast, gastric, and colorectal cancer research, evaluating biomarkers like miRNAs, HLA-G, and FOXP3, and exploring innovative cancer therapies using viral vectors and nanotechnology. His interdisciplinary approach blends molecular biology, bioinformatics, and pharmacogenomics to enhance patient outcomes and reduce cancer mortality through early, personalized interventions.

Publication Top Notes

📄 Evaluation of the in vitro and in vivo effect of liposomal doxorubicin with Newcastle disease virus on 4T1 cell line (2023)
📄 Plasma miR-183-5p as a predictive lymph node metastasis marker in colorectal cancer (2022)
📄 Effect of testosterone enanthate on liver Irs-2 mRNA expression in PCOS model rats (2021)
📄 Meta-analysis of serum HLA-G level accuracy in breast cancer diagnosis (2020)
📄 Expression of angiogenesis-related genes in Iranian breast cancer patients (2020)
📄 Epidemiological study of postsurgical invasive breast cancer cases in Iran (2020)
📄 Use of software in detecting angiogenesis in breast tissue slides (2020)
📄 Meta-analysis of FOXP3 polymorphisms and multiple sclerosis susceptibility (2020)
📄 Evaluation of miR-21 and miR-222 as diagnostic biomarkers for gastric cancer (2019)
📄 Nanocomposite scaffold with MSCs for bone repair applications (2019)
📄 Study on protein-binding malondialdehyde in breast cancer tissues (2019)
📄 Management of biotechnology industry in the West and solutions for Iran (2018)
📄 In vitro effects of Lactobacillus reuteri on gastric cancer progression (2017)
📄 Implementation of private sector cancer prevention programs in Iran (2017)
📄 Study on BRCA1/2 mutations in women with breast cancer family history (2016)
📄 Anti-fibronectin gold nanoparticle biosensor for ECM detection (2014)
📄 Iranian consumers’ shift to functional foods for healthier lifestyle (2014)
📄 FOXP3 mRNA downregulation by Alkanna Frigida extract (2013)
📄 H-semigroup structure on F-offspring of a gene pool (2012)

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Published on by Citation Awards

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

William Agbozo, Morehouse School of Medicine, Atlanta, GA 30310, USA. United States

William Kwaku Agbozo is a passionate Ghanaian biomedical researcher specializing in molecular and cell biology, particularly in the context of hemolysis-related complications in sickle cell disease and cerebral malaria. With a strong academic foundation from the University of Ghana, he has cultivated expertise through interdisciplinary training in physiology, biochemistry, and molecular sciences. Currently serving as a Research Scholar at Morehouse School of Medicine, Atlanta, he brings his research to life by utilizing advanced genomics and proteomics tools in both animal and human studies. His work has yielded peer-reviewed publications and international presentations, reflecting a commitment to translational science aimed at uncovering therapeutic targets. William has also made significant contributions as a lecturer at Central University, Ghana, mentoring students and guiding research projects. His career is driven by a desire to bridge clinical gaps in infectious and genetic diseases, focusing on real-world biomedical challenges in Africa and beyond.

Publication Profile

orcid

Education

William Agbozo’s academic journey began at the University of Ghana, where he earned his Bachelor of Science in Biochemistry (2008–2012). He continued at the same institution to pursue a Master of Philosophy in Physiology (2013–2015), equipping him with in-depth knowledge of human physiological mechanisms. Motivated by a growing interest in translational biomedical research, he embarked on a PhD in Molecular and Cell Biology (2018–2024, Viva pending), also at the University of Ghana. Throughout his academic path, William has maintained a strong interdisciplinary focus—integrating molecular biology, physiology, and cell biology with practical research on diseases like sickle cell and malaria. His PhD was conducted under the prestigious West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), supported by multiple international grants, where he gained valuable skills in omics technologies and disease modeling. His academic training reflects both scientific rigor and a deep-rooted commitment to addressing health burdens in Africa.

Experience

William Agbozo has over six years of academic and research experience. From 2017 to 2023, he worked as a Lecturer at the School of Medicine and Health Sciences, Central University, Accra, where he taught undergraduate physiology and supervised research and academic writing. In 2023, he transitioned to the Morehouse School of Medicine in Atlanta, USA, as a Research Scholar in the Department of Microbiology, Biochemistry & Immunology. At Morehouse, he is engaged in conceptualizing research ideas, contributing to grant proposals, and conducting laboratory experiments in molecular and translational research. He also leads data analysis and presents at major scientific meetings. His work spans across both African and U.S.-based biomedical institutions, reinforcing a global collaborative perspective. His experience reflects a balance of education, research, mentorship, and scientific communication, aimed at producing actionable insights for health systems managing genetic and infectious diseases.

Awards and Honors

William Agbozo has received several prestigious awards in recognition of his academic excellence and impactful research. He was awarded a PhD Fellowship (2018–2024) from the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) under the World Bank African Centres of Excellence (ACE) initiative. Between 2019 and 2023, he secured research funding support from the Sickle Cell Disease Genomics Network of Africa (SickleGenAfrica), funded by the National Heart, Lung, & Blood Institute (U54HL141011). His scientific aptitude also earned him a place in the US Exchange Visitor Program as a research scholar at Morehouse School of Medicine (2023–2025), under the National Institute of Neurological Disorders and Stroke (R01NS125775). These honors reflect both his research potential and his growing international reputation in the fields of sickle cell disease and molecular medicine. They have empowered him to explore groundbreaking discoveries using both human samples and experimental models.

Research Focus

William Agbozo’s research centers on the molecular mechanisms of hemolysis-mediated injury in diseases such as sickle cell disease (SCD) and human cerebral malaria (HCM). His work investigates how excess free heme contributes to acute kidney injury (AKI) and brain damage, using humanized sickle cell mouse models and post-mortem human samples. He applies cutting-edge genomics and proteomics to map signaling pathways and identify biomarkers that may serve as protective or therapeutic targets. Through his research, William aims to bridge molecular biology with translational applications, developing insights that could lead to novel treatments or interventions. His work is especially impactful in regions heavily burdened by malaria and genetic blood disorders. By collaborating across institutions in Ghana and the United States, he brings an interdisciplinary and international lens to pressing biomedical problems affecting both African and global populations.

Publication Top Notes

📄 Hydroxyurea Mitigates Heme-Induced Inflammation and Kidney Injury in Humanized Sickle Cell Mice. (2025)
📄 Circulating biomarkers associated with pediatric sickle cell disease. (2024)
📄 Assessing knowledge of sickle cell disease and health beliefs on premarital genetic screening among healthcare trainees at a tertiary institution: A cross‐sectional study. (2023)
📄 Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghanaian tertiary hospital. (2022)
📄 Phosphomolybdenum Blue Detection – A Review of Characteristics, Achievements, Challenges and Future Prospects. (2020)
📄 Frequencies and ethnic distribution of ABO and RhD blood groups in the Volta region of Ghana, towards effective blood bank services. (2022)
📄 Frequency of ABO/Rhesus (D) blood groupings and ethnic distribution in the Greater‐Accra region of Ghana, towards effective blood bank inventory. (2019)
📄 Neuregulin-1 attenuates hemolysis-mediated kidney injury in humanized sickle cell mice. (Submitted)